Atlas Trials

Metastatic Melanoma Stage IV

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Melanoma Stage IV

RecordFirmDate
A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma (NCT02076646)Philogen S.p.A.2013-07-31

Track Metastatic Melanoma Stage IV automatically

Every clearance here is in the API, with alerts when new ones post.